Spelling suggestions: "subject:"howshow patients"" "subject:"showshow patients""
1 |
Effektivare resursanvändning vid återbesök inom psykiatrisk öppenvård : Utveckling, test och erfarenheter av digitala vårdmöten / More efficient use of resources for revisits in psychiatric outpatient care : Development, testing and experience of digital healthcare meetingsHolm Löv, Marita January 2018 (has links)
Bakgrund Hög andel sena återbud och uteblivna besök, är ett problem vid psykiatriska kliniker och orsakar effektivitetsbrister då tillgängliga resurser inte används optimalt. Fysiska besök och telefonkontakter behöver kompletteras med fler mötesformer för att bättre möta patientens behov och öka tillgängligheten. Syfte Syfte och övergripande mål med förbättringsarbetet var att öka tillgängligheten till psykiatrisk öppenvård genom att erbjuda digitala vårdmöten. Syftet med studien av förbättringsarbetet var att identifiera erfarenheter från förbättringsarbetet som kan användas som lärdomar i fortsatt verksamhetsutveckling. Metod Nolans förbättringsmodell har används i förbättringsarbetet. Studien är en fallstudie, inspirerad av interaktiv ansats med kvalitativ metod. Resultat Genom utveckling och genomförande av 20 digitala vårdmöten är lärdomarna att digitala vårdmöten är ett komplement till besök på mottagning och att digital teknik stödjer arbetsprocessen. Studiens resultat visar att ledningen, strukturer och medarbetares delaktighet är centrala vid kvalitetsförbättringar. Slutsatser Inställning till patientens kapacitet och digital teknik är central för att erbjuda mötesformen. Tekniska lösningar måste vara lättillgängliga. För att dela kunskap, öka tryggheten i det nya sättet att mötas och undanröja hinder som uppstår är arbetsmöten viktiga. Ledningen utgör en central roll för att påverka förbättringskulturen och de värderingar och mönster som finns i verksamheten.
|
2 |
Treatment Adherence in Digital Psychotherapy Using Machine Learning to Predict Patient No-showsHan, Helén January 2023 (has links)
Background: Untreated patients and discontinuity in treatments are problems that mental health care is facing. Even though people seek care, there is still a pattern of patients who do not attend their scheduled appointments, referred to as No-shows. Noshows result in prolonged waiting times for patients and decreased efficiency and workflow for healthcare professionals. Moreover, causing great financial costs and losses for the healthcare sector. Using machine learning to predict potential No-shows beforehand could be a possible solution to minimize No-shows, while enhancing treatment adherence. Aim: The aim is to explore the best-performing algorithm for No-show predictions in digital psychotherapy. Furthermore, gaining a deeper knowledge of common behaviors in patient demographic and appointment data that may explain the reasons behind No-shows in digital mental health care services. Methods: A quantitative experimental research methodology and design with an inductive approach were utilized, incorporating computational methods, tools, and techniques. The Knowledge Discovery in Databases process was used as a guidance in the data mining process. Results: An observational relationship was found between No-shows and the following features age, day of the week of the appointment, date in a month of the appointment, month of the appointment, and waiting time. The best-performing algorithms to predict No-shows were Gradient Boosting Decision Tree and Random Forest. The date in a month was the most impactful feature for both classifiers, followed by the appointment month, the day of the week, and the number of waiting days. Conclusion: Machine learning has the potential to predict No-shows in digital psychotherapy and can be used to identify the underlying factors and patterns behind Noshows while providing useful information to support and improve digital mental health care delivery, treatment adherence, and patient outcomes. Thus, predicting No-shows beforehand is highly relevant for enhancing treatment adherence in digital psychotherapy and mental health care.
|
3 |
Avaliação assistencial da população atendida no ambulatório A2MG404 (Hepatite B) da Divisão de Gastroenterologia e Hepatologia Clínica do HC-FMUSP / Assistance assessment of the population served at the ambulatory A2MG404 (Hepatitis B) of the Division of Gastroenterology and Clinical Hepatology of HCFMUSPSouza, Felipe Pereira de 22 May 2018 (has links)
Introdução: A infecção pelo vírus da Hepatite B (HBV) é um grande problema de saúde pública, uma vez que cerca de 257 milhões de pessoas em todo o mundo são acometidas pelo vírus. Mundialmente, devido ao grande movimento migratório, descrevem-se mudanças no perfil dos pacientes portadores de HBV. Desta forma, objetivamos caracterizar a população de pacientes portadores HBV atendidos no ambulatório A2MG404 de Hepatites Virais do HC-FMUSP. Métodos: Este foi um estudo retrospectivo descritivo de 617 novos pacientes com exames sorológicos positivos para HBV, em seguimento no ambulatório A2MG404 entre janeiro de 2005 e dezembro de 2015. Dados demográficos, epidemiológicos e clínicos foram obtidos de prontuários eletrônicos institucionais (SIGH-PRODESP, HCMED e ProntMed). A coleta e gerenciamento de dados foi realizada utilizando o software on-line REDCap (V6.16.4). A análise estatística foi realizada utilizando o software R (V3.3.0). O teste de Shapiro-Wilk foi utilizado para testar a normalidade dos dados; dados não paramétricos foram comparados utilizando-se o teste de Wilcoxon-Mann-Whitney; as proporções entre populações foram comparadas utilizando-se o Teste Z. Foram considerados estatisticamente significativos valores de p < 0,05. Resultados: Foi observada predominância do sexo masculino (60,9%); mediana de idade de 48 anos; raça branca (70,8%) e nível de escolaridade baixo [ensino fundamental completo (37,4%)] entre os pacientes. A maioria deles eram brasileiros (93,5%), residentes no estado de São Paulo (98,4%), principalmente na cidade de São Paulo (63,6%). Pacientes residentes em outros estados do Brasil também foram atendidos no serviço (1,6%), bem como estrangeiros (6,5%). Coinfecção por HCV foi identificada em 7,8% dos pacientes; e por HIV em 1,3% destes. De base, 109/617 (17,66%) pacientes eram AgHBe positivo [infecção crônica: 42/617 (6,8%); hepatite crônica: 67/617 (10,8%)]; 350/617 (56,72%) pacientes eram AgHBe negativo [infecção crônica: 290/617 (47,0%); hepatite crônica: 60/617 (9,7%)]; 104/617 (16,9%) pacientes eram Anti-HBc Total e Anti-HBs positivos; 49/617 (8,0%) pacientes eram Anti-HBc Total isolado; e 5/617 (0,8%) pacientes eram portadores de perfil sorológico anômalo da hepatite B. Entre o início e término de seguimento foram observados diminuição significativa dos valores de ALT, AST, APRI, carga viral (p < 0,001), hemoglobina (p=0,007) e bilirrubina total (p=0,011), bem como aumento significativo de bilirrubina direta e INR (p < 0,001). O FIB-4 não apresentou diferença estatisticamente significativa no mesmo intervalo. A análise mostra que 30,3% dos pacientes receberam tratamento com antivirais, sendo Tenofovir (28,3%) o mais prescrito, seguido de Lamivudina (19,8%), Tenofovir+Lamivudina (19,8%) e Entecavir (19,2%). Entecavir apresentou a maior taxa de soroconversão de AgHBe (6/9; 66,66%), enquanto que Lamivudina apresentou a maior taxa para AgHBs (5/30; 16,66%). Tenofovir possui maior potencial para redução de carga viral, aumento de plaquetas e melhora de enzimas hepáticas do que Lamivudina e Entecavir (p < 0,05). No total, foram realizadas 5412 consultas médicas, sendo a maioria delas do tipo \"seguimento\" (85,8%). Faltas foram registradas em 11,9% das consultas médicas agendadas no período. Conclusões: A população atendida no serviço é heterogênea, com representação de diferentes sexos, etnias, faixas etárias e nacionalidades; ao menos 14 nacionalidades representadas, refletindo o fenômeno da migração observado globalmente. São necessárias ações educacionais para promoção da adesão aos cuidados médicos adequados / Background: Hepatitis B virus (HBV) is a major public health problem with significant burden across all global regions, once they affect about 250 million people around the world. Worldwide, due to the great migratory movement, changes were described in the profile of patients with hepatitis B. In this way, we aimed to characterize the population of patients with chronic hepatitis B seen in the ambulatory A2MG404 of Viral Hepatitis of HC-FMUSP. Methods: This was a retrospective descriptive study of 617 new patients with positive serological tests results for HBV, followed up in the A2MG404 ambulatory between January 2005 and December 2015. Demographic, epidemiological and clinical data were obtained from institutional electronic medical records (SIGH-PRODESP, HCMED and ProntMed). Data collection and management was performed using REDCap online software (V6.16.4). Statistical analysis was performed using R software (V3.3.0). Shapiro-Wilk Test was used to test the normality of the data; non-parametric data were compared using Wilcoxon-Mann-Whitney Test; proportions among populations were compared using the Z-Test. Values of p < 0.05 were considered statistically significant. Results: Male predominance (60.9%); median age of 48 years; white race (70.8%) and low educational level (37.4%) was observed among the patients. Most of them were Brazilian (93.5%), living in the State of São Paulo (98.4%), mainly in the city of São Paulo (63.6%). Patients living in other Brazilian states were also assisted in the service (1.6%), as well as foreigners (6.5%). HCV coinfection were identified in 7.8% of patients; and HIV in 1.3% of these. At baseline, 109/617 (17.66%) patients were HBeAg positive [chronic infection: 42/617 (6.8%); chronic hepatitis: 67/617 (10.8%)]; 350/617 (56.72%) patients were HBeAg negative [chronic infection: 290/617 (47.0%); chronic hepatitis: 60/617 (9.7%)]; 104/617 (16.9%) patients were Total Anti-HBc and Anti-HBs positive; 49/617 (8.0%) patients were Anti-HBc Total isolated; and 5/617 (0.8%) patients had anomalous serological profile of hepatitis B. Significant decrease in ALT, AST, APRI, viral load (p < 0.001), hemoglobin (p = 0.007) and total bilirubin (p = 0.011); as well as significant increase of direct bilirubin and INR (p < 0.001) of patients were observed during the follow-up. FIB-4 score didn\'t present a statistically significant difference in the same interval. The analysis shows that 30.3% of the patients received antiviral treatment, being Tenofovir (28.3%) the most prescribed, followed by Lamivudine (19.8%), Tenofovir+Lamivudine (19.8%) and Entecavir (19.2%). Entecavir presented the highest HBeAg seroconversion rate (6/9; 66.66%), whereas Lamivudine presented the highest rate for HBsAg (5/30, 16.66%). Tenofovir has greater potential for viral load reduction, platelet increase, and hepatic enzymes normalization than Lamivudine and Entecavir (p < 0.05). In total, 5412 medical appointment were performed, most of them was classified as \"follow up\" type (85.8%). Absences were recorded in 11.9% of the medical appointments scheduled in the period. Conclusions: The population served in the service is heterogeneous, with representation of different genders, ethnicities, age groups and nationalities. In it, at least 14 nationalities are represented, reflecting the phenomenon of immigration observed worldwide. Educational actions are required to promote adherence to the necessary medical care for these patients
|
4 |
Avaliação assistencial da população atendida no ambulatório A2MG404 (Hepatite B) da Divisão de Gastroenterologia e Hepatologia Clínica do HC-FMUSP / Assistance assessment of the population served at the ambulatory A2MG404 (Hepatitis B) of the Division of Gastroenterology and Clinical Hepatology of HCFMUSPFelipe Pereira de Souza 22 May 2018 (has links)
Introdução: A infecção pelo vírus da Hepatite B (HBV) é um grande problema de saúde pública, uma vez que cerca de 257 milhões de pessoas em todo o mundo são acometidas pelo vírus. Mundialmente, devido ao grande movimento migratório, descrevem-se mudanças no perfil dos pacientes portadores de HBV. Desta forma, objetivamos caracterizar a população de pacientes portadores HBV atendidos no ambulatório A2MG404 de Hepatites Virais do HC-FMUSP. Métodos: Este foi um estudo retrospectivo descritivo de 617 novos pacientes com exames sorológicos positivos para HBV, em seguimento no ambulatório A2MG404 entre janeiro de 2005 e dezembro de 2015. Dados demográficos, epidemiológicos e clínicos foram obtidos de prontuários eletrônicos institucionais (SIGH-PRODESP, HCMED e ProntMed). A coleta e gerenciamento de dados foi realizada utilizando o software on-line REDCap (V6.16.4). A análise estatística foi realizada utilizando o software R (V3.3.0). O teste de Shapiro-Wilk foi utilizado para testar a normalidade dos dados; dados não paramétricos foram comparados utilizando-se o teste de Wilcoxon-Mann-Whitney; as proporções entre populações foram comparadas utilizando-se o Teste Z. Foram considerados estatisticamente significativos valores de p < 0,05. Resultados: Foi observada predominância do sexo masculino (60,9%); mediana de idade de 48 anos; raça branca (70,8%) e nível de escolaridade baixo [ensino fundamental completo (37,4%)] entre os pacientes. A maioria deles eram brasileiros (93,5%), residentes no estado de São Paulo (98,4%), principalmente na cidade de São Paulo (63,6%). Pacientes residentes em outros estados do Brasil também foram atendidos no serviço (1,6%), bem como estrangeiros (6,5%). Coinfecção por HCV foi identificada em 7,8% dos pacientes; e por HIV em 1,3% destes. De base, 109/617 (17,66%) pacientes eram AgHBe positivo [infecção crônica: 42/617 (6,8%); hepatite crônica: 67/617 (10,8%)]; 350/617 (56,72%) pacientes eram AgHBe negativo [infecção crônica: 290/617 (47,0%); hepatite crônica: 60/617 (9,7%)]; 104/617 (16,9%) pacientes eram Anti-HBc Total e Anti-HBs positivos; 49/617 (8,0%) pacientes eram Anti-HBc Total isolado; e 5/617 (0,8%) pacientes eram portadores de perfil sorológico anômalo da hepatite B. Entre o início e término de seguimento foram observados diminuição significativa dos valores de ALT, AST, APRI, carga viral (p < 0,001), hemoglobina (p=0,007) e bilirrubina total (p=0,011), bem como aumento significativo de bilirrubina direta e INR (p < 0,001). O FIB-4 não apresentou diferença estatisticamente significativa no mesmo intervalo. A análise mostra que 30,3% dos pacientes receberam tratamento com antivirais, sendo Tenofovir (28,3%) o mais prescrito, seguido de Lamivudina (19,8%), Tenofovir+Lamivudina (19,8%) e Entecavir (19,2%). Entecavir apresentou a maior taxa de soroconversão de AgHBe (6/9; 66,66%), enquanto que Lamivudina apresentou a maior taxa para AgHBs (5/30; 16,66%). Tenofovir possui maior potencial para redução de carga viral, aumento de plaquetas e melhora de enzimas hepáticas do que Lamivudina e Entecavir (p < 0,05). No total, foram realizadas 5412 consultas médicas, sendo a maioria delas do tipo \"seguimento\" (85,8%). Faltas foram registradas em 11,9% das consultas médicas agendadas no período. Conclusões: A população atendida no serviço é heterogênea, com representação de diferentes sexos, etnias, faixas etárias e nacionalidades; ao menos 14 nacionalidades representadas, refletindo o fenômeno da migração observado globalmente. São necessárias ações educacionais para promoção da adesão aos cuidados médicos adequados / Background: Hepatitis B virus (HBV) is a major public health problem with significant burden across all global regions, once they affect about 250 million people around the world. Worldwide, due to the great migratory movement, changes were described in the profile of patients with hepatitis B. In this way, we aimed to characterize the population of patients with chronic hepatitis B seen in the ambulatory A2MG404 of Viral Hepatitis of HC-FMUSP. Methods: This was a retrospective descriptive study of 617 new patients with positive serological tests results for HBV, followed up in the A2MG404 ambulatory between January 2005 and December 2015. Demographic, epidemiological and clinical data were obtained from institutional electronic medical records (SIGH-PRODESP, HCMED and ProntMed). Data collection and management was performed using REDCap online software (V6.16.4). Statistical analysis was performed using R software (V3.3.0). Shapiro-Wilk Test was used to test the normality of the data; non-parametric data were compared using Wilcoxon-Mann-Whitney Test; proportions among populations were compared using the Z-Test. Values of p < 0.05 were considered statistically significant. Results: Male predominance (60.9%); median age of 48 years; white race (70.8%) and low educational level (37.4%) was observed among the patients. Most of them were Brazilian (93.5%), living in the State of São Paulo (98.4%), mainly in the city of São Paulo (63.6%). Patients living in other Brazilian states were also assisted in the service (1.6%), as well as foreigners (6.5%). HCV coinfection were identified in 7.8% of patients; and HIV in 1.3% of these. At baseline, 109/617 (17.66%) patients were HBeAg positive [chronic infection: 42/617 (6.8%); chronic hepatitis: 67/617 (10.8%)]; 350/617 (56.72%) patients were HBeAg negative [chronic infection: 290/617 (47.0%); chronic hepatitis: 60/617 (9.7%)]; 104/617 (16.9%) patients were Total Anti-HBc and Anti-HBs positive; 49/617 (8.0%) patients were Anti-HBc Total isolated; and 5/617 (0.8%) patients had anomalous serological profile of hepatitis B. Significant decrease in ALT, AST, APRI, viral load (p < 0.001), hemoglobin (p = 0.007) and total bilirubin (p = 0.011); as well as significant increase of direct bilirubin and INR (p < 0.001) of patients were observed during the follow-up. FIB-4 score didn\'t present a statistically significant difference in the same interval. The analysis shows that 30.3% of the patients received antiviral treatment, being Tenofovir (28.3%) the most prescribed, followed by Lamivudine (19.8%), Tenofovir+Lamivudine (19.8%) and Entecavir (19.2%). Entecavir presented the highest HBeAg seroconversion rate (6/9; 66.66%), whereas Lamivudine presented the highest rate for HBsAg (5/30, 16.66%). Tenofovir has greater potential for viral load reduction, platelet increase, and hepatic enzymes normalization than Lamivudine and Entecavir (p < 0.05). In total, 5412 medical appointment were performed, most of them was classified as \"follow up\" type (85.8%). Absences were recorded in 11.9% of the medical appointments scheduled in the period. Conclusions: The population served in the service is heterogeneous, with representation of different genders, ethnicities, age groups and nationalities. In it, at least 14 nationalities are represented, reflecting the phenomenon of immigration observed worldwide. Educational actions are required to promote adherence to the necessary medical care for these patients
|
Page generated in 0.0447 seconds